U.S. pharmaceutical industry

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about the U.S. pharmaceutical industry

This dossier presents graphs and tables about the U.S. pharmaceutical industry. The U.S. pharma industry has a huge influence on the global pharmaceutical market. This document includes some of the most important key figures on U.S. revenues, top companies, top products, medicine use facts, research and development, and an outlook for the coming years.

Table of contents

  • 1. Contribution to global pharma
    • World pharmaceutical market distribution by submarket 2014-2018

    • World pharmaceutical sales 2016-2018 by region

    • Market share of the leading 10 global pharmaceutical markets 2017

    • Top 10 global pharmaceutical markets: growth 2012-2017

    • Top 50 pharmaceutical companies - Rx sales and R&D spending 2018

    • Leading countries in life sciences sector M&As 2019

  • 2. Overview
    • U.S. total medicine spending 2002-2018

    • Leading therapy areas for U.S. drug spending 2018

    • U.S. top 20 prescribed drugs based on sales 2018

    • Top U.S. pharma products by prescriptions 2018

    • Pharmaceutical channel distribution by U.S. spending 2014-2018

    • U.S. biopharmaceutical export volume 2002-2017

  • 3. Companies
    • 2019 list of top U.S. biotech and pharmaceutical companies based on revenue

    • Pharmaceutical corporations by U.S. revenue 2018

    • Pfizer's total revenue 2006-2018

    • Johnson & Johnson's total revenue 2005-2018

    • AbbVie's revenue 2010-2018

  • 4. Research and development
    • Research and development expenditure: U.S. pharmaceutical industry 1995-2018

    • U.S. pharma industry R&D spending as a percent of total revenues 1990-2018

    • Pharmaceuticals: biopharma medicines in development in 2019, by category

    • Pharmaceuticals: cost of drug development in the U.S. since 1975

    • Number of novel drugs approved annually by CDER 2008-2018

    • Number of orphan designations accepted in the U.S. 2003-2018

    • U.S. sales growth of new brand medicines 2014-2018

    • R&D expenditure per employee in U.S. sectors 2001-2015

  • 5. Generics
    • Unbranded generics revenue top corporations in U.S. 2016-2017

    • Spending change on branded and generic medicines in the U.S. 2013-2018

    • U.S. brand and generic prescription drug revenue 2005-2018

    • Branded vs. generic U.S. drug prescriptions dispensed 2005-2018

    • Savings through generic drug usage in the U.S. 2008-2018

    • Projected decrease in brand drug spending due to patent loss in the U.S. 2013-2023

  • 6. Outlook
    • World pharmaceutical sales by region forecast 2022

    • Top branded biologic drugs in the U.S. that will go generic by 2028

    • Leading U.S. pharmaceutical products by revenue 2024

    • Projected 2024 revenue for top drugs approved U.S. 2018

    • U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection

  • 7. The consumer's view
    • U.S. adults impression of the U.S. pharma industry

    • U.S. adults that believe physicians are under pressure from pharma to prescribe drugs

    • U.S. adults impression of the U.S. pharma drug qualities

    • U.S. adults impression of the U.S. pharma companies fairness towards patients

    • U.S. adults who would rate selected pharma features as excellent or good 2017

    • Preferred pharma companies by Americans for drug purchase 2017

    • Americans on US pharma quality compared to foreign pharma 2017

More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!